Dr Allen's Device is the only safe treatment to reduce the size of an enlarged prostate gland due to benign prostatic hyperplasia (BPH), treating lower urinary tract symptoms (LUTS).
BPH is not cancer and primarily requires careful and safe treatment that does not interfere with men’s daily life. Men should note that BPH is diagnosed in about 50% of men over 50. The incidence of prostate enlargement increases with age, reaching 90 percent in men over 80.
The effectiveness and safety of Dr Allen’s Device for Prostate Treatment has been proven in the controlled clinical trials. According to a scientific article: “Innovative Thermobalancing therapy and Dr Allen's Device for the first time employ body energy to treat chronic prostatic diseases effectively”, published in the leading medical journal, this device reduces the abnormal size of the enlarged prostate without side effects.
Standard BPH treatments drugs and surgeries are risky
The standard treatment options for BPH are medications and surgery, which have serious side effects, including sexual and erectile dysfunction, impotence, and diabetes. These new health conditions can cause additional mental problems and depression.
A medical article published in September 2021, “The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction” states that most treatments for LUTS associated with BPH result in ejaculatory dysfunction (ED), manifest as anejaculation, decreased ejaculation, retrograde ejaculation, painful ejaculation or premature ejaculation, and male fertility.
After BPH surgery, patients attach great importance to maintaining their sexual function, which can be irreversibly impaired.
Out-of-hospital use of Dr Allen’s Device is side effects free
Dr Allen’s Device has been registered with the Medical Regulatory Healthcare Agency in Great Britain since 2010, as a class 1 medical device that cannot harm. So, its safety is confirmed over the decade. This exclusive device and Thermobalancing therapy received a patent issued by the US Patent and Trademark Office, confirming the uniqueness of this treatment for BPH.
The Aging Male journal published the article “Use of Thermobalancing therapy in ageing male with benign prostatic hyperplasia with a focus on etiology and pathophysiology”, which explains that Dr Allen’s Device treats the cause of BPH by improving blood circulation in the affected prostate, reducing enlargement of the prostate and urinary symptoms dramatically.
Fine Treatment produces and distributes Dr Allen’s Device
Thermobalancing treatment is used by people at home for over ten years successfully. The use of Dr Allen’s Device at home is important as it protects men from visiting clinics and hospitals, which are the most dangerous place for contracting a coronavirus infection.
Fine Treatment https://finetreatment.com/ manufactures Dr Allen’s Devices in the United Kingdom and makes them available worldwide, with free international delivery. Thousands of Fine Treatment’s customers with LUTS due to BPH across 100 countries have already benefited from this powerful and safe Thermobalancing therapy without BPH drugs and surgeries.
This article does not necessarily reflect the opinions of the editors or the management of EconoTimes


SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Anta Sports Expands Global Footprint With Strategic Puma Stake
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 



